Bonraybio Co., Ltd. (TWSE: 6955)
Health Care · Biotechnology · TW
NT$93.00
-0.53% today · -31.0% 1Y
Bonraybio Co., Ltd. (TWSE: 6955) operates in the Biotechnology industry within the Health Care sector. The company is valued at $88.36M.
Over the last twelve months the share price has lost 31.0%, trading between 88.98 and 144.49.
Tweenvest scores Bonraybio Co., Ltd. across four factors: quality 77/100, value 71/100, growth 100/100, dividend 20/100. Its strongest factor is growth.
6955 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $88.36M
- Revenue (TTM)
- $10.44M
- P/E
- 26.25
- EPS
- 3.54
- Dividend yield
- 1.32%
- Beta (5Y)
- 0.13
- 52-week high
- NT$144.49
- 52-week low
- NT$88.98
- Avg volume (3M)
- —
- Shares outstanding
- 30.38M
- Employees
- —
- Next earnings
- —
About Bonraybio Co., Ltd.
Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded in 2015 and is based in Taichung, Taiwan.
- ISIN
- TW0006955008
- Founded
- 2015
- Listed since
- Dec 6, 2024
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Equillium, Inc.NasdaqCM: EQ | $89.41M | $1.38 | -2.48% |
| ViGenCell Inc.KOSDAQ: A308080 | $89.05M | ₩5,840.00 | +0.52% |
| ImmuCell CorporationNasdaqCM: ICCC | $89.01M | $10.51 | +7.24% |
| Citius Oncology, Inc.NasdaqCM: CTOR | $88.82M | $0.78 | -6.88% |
| Y-Biologics, Inc.KOSDAQ: A338840 | $87.21M | ₩7,630.00 | -10.45% |
| Revium Rx.OTCPK: RVRC | $86.84M | $— | — |
| Quantum Cyber N.V.NasdaqCM: QUCY | $86.59M | $1.06 | +2.91% |
| Devyser Diagnostics AB (publ)OM: DVYSR | $85.81M | Skr50.80 | 0.00% |
Figures last refreshed Oct 11, 2026.